PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/BHB
Metabolic & Glycemic ControlHepatic Ketogenesis & Mitochondrial Epigenetics

Serum Beta-Hydroxybutyrate (BHB)

Beta-hydroxybutyrate is the principal circulating ketone body synthesized by hepatic mitochondria from fatty acid beta-oxidation during fasting or carbohydrate restriction.

Standard Range< 0.5 mmol/L (Nutritional Ketosis: 0.5 - 3.0 mmol/L)
Optimal Longevity0.3 - 1.5 mmol/L (Targeted Fasting / Ketogenic States)
Measurement Unitmmol/L
Organ SystemHepatic Ketogenesis & Mitochondrial Epigenetics
Routine Panels:Ketone Body QuantificationMetabolic Flexibility Profile

Standard vs. Optimal Reference Rangesmmol/L

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: mmol/L
mmol/L
Presets:
0 mmol/LOptimal Zone Target5 mmol/L
Optimal Longevity Zone(0.9 mmol/L)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

< 0.5 mmol/L (Nutritional Ketosis: 0.5 - 3.0 mmol/L)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

0.3 - 1.5 mmol/L (Targeted Fasting / Ketogenic States)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

HMG-CoA synthase generates acetoacetate, which beta-hydroxybutyrate dehydrogenase reduces to BHB. Beyond serving as a clean cellular energy substrate, BHB acts as an endogenous histone deacetylase (HDAC) inhibitor, upregulating FoxO3a and antioxidant defenses.

Differential Diagnosis

Elevated Levels (BHB High)

  • •Nutritional ketosis (prolonged fasting, ketogenic diet)
  • •Diabetic ketoacidosis (severe, >3.0-5.0 mmol/L with hyperglycemia)
  • •Alcoholic ketoacidosis

Low Levels (BHB Low)

  • •Postprandial state with elevated insulin suppressing lipolysis

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
The physiological homeostasis of Serum Beta-Hydroxybutyrate (BHB) is governed by pancreatic islet beta-cell secretion, hepatic gluconeogenesis, skeletal muscle GLUT4 glucose transporter translocation, and peripheral insulin sensitivity. Cellular signal transduction occurs via the insulin receptor tyrosine kinase (IRTK), triggering phosphorylation of IRS-1 and IRS-2, which activates the phosphatidylinositol 3-kinase (PI3K)-Akt cascade and downregulates FOXO1 transcription factors. Impaired signaling causes systemic hyperinsulinemia, attenuated mitochondrial beta-oxidation, and accelerated hepatic de novo lipogenesis (DNL).
Longevity Risk Architecture & Epidemiology
Periodic elevations of BHB stimulate cellular autophagy, activate the Nrf2 antioxidant response, and inhibit the pro-inflammatory NLRP3 inflammasome.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Strict 10 to 12 hour overnight water-only fasting is mandatory for baseline metabolic quantification. Acute psychological stress, acute infectious illness, and sleep deprivation (<6 hours) transiently elevate cortisol and catecholamines, falsely elevating glycemic markers. For glucose and insulin testing, draw blood into sodium fluoride/potassium oxalate tubes or separate serum promptly within 30 minutes to prevent ongoing in vitro red blood cell glycolysis.

Reflexive Testing Protocol:

  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and HOMA-Beta calculations
  • Continuous Glucose Monitoring (CGM) 14-day wear to evaluate glycemic variability and postprandial excursions
  • Fasting C-Peptide and high-sensitivity Troponin/hs-CRP to differentiate insulin resistance from beta-cell exhaustion
  • Oral Glucose Tolerance Test (OGTT) with simultaneous 0, 30, 60, and 120-minute insulin assays
  • Abdominal ultrasound or FibroScan to evaluate hepatic steatosis and non-alcoholic fatty liver disease (MASLD)
Clinical Citations & Primary Literature (1)
  • [1]Beta-Hydroxybutyrate: A Signaling Metabolite in Longevity and Epigenetics - Cell Metabolism (2021). PMID: 33497625
Common Panels:Ketone Body QuantificationMetabolic Flexibility Profile
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Beta-Hydroxybutyrate (BHB) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

Fasting Blood Glucose
FBG · 75 - 85 mg/dL
Fasting Serum Insulin
Fasting Insulin · 2.0 - 5.0 μIU/mL
Serum Free Fatty Acids (Non-Esterified)
FFA · 0.15 - 0.45 mmol/L (Fasting)
PreviousFasting Plasma Lactic Acid (Lactate) (Lactate)Metabolic & Glycemic ControlNextSerum Free Fatty Acids (Non-Esterified) (FFA)Metabolic & Glycemic Control